DK517588A - L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse - Google Patents

L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse

Info

Publication number
DK517588A
DK517588A DK517588A DK517588A DK517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A
Authority
DK
Denmark
Prior art keywords
optionally substituted
denotes
preparation
additional salts
acid additional
Prior art date
Application number
DK517588A
Other languages
English (en)
Other versions
DK517588D0 (da
Inventor
Yoshimi Tsuchiya
Masahiro Hayashi
Hiroshi Takehana
Akihiro Hisaka
Yoshio Sawasaki
Masaki Ihara
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of DK517588D0 publication Critical patent/DK517588D0/da
Publication of DK517588A publication Critical patent/DK517588A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK517588A 1987-09-18 1988-09-16 L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse DK517588A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23429987 1987-09-18
JP3126088 1988-02-13

Publications (2)

Publication Number Publication Date
DK517588D0 DK517588D0 (da) 1988-09-16
DK517588A true DK517588A (da) 1989-03-19

Family

ID=26369718

Family Applications (1)

Application Number Title Priority Date Filing Date
DK517588A DK517588A (da) 1987-09-18 1988-09-16 L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4966915A (da)
EP (1) EP0309827B1 (da)
JP (1) JPH02138A (da)
KR (1) KR890005031A (da)
CN (1) CN1032785A (da)
AT (1) ATE71083T1 (da)
AU (1) AU2234088A (da)
CA (1) CA1316180C (da)
DE (1) DE3867403D1 (da)
DK (1) DK517588A (da)
IL (1) IL87765A0 (da)
PT (1) PT88526B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314189T3 (es) * 2002-02-15 2009-03-16 Darpharma, Inc. Profarmacos monoester y diester asimetricamente sustituidos de los agonistas del receptor d1 de dopamina.
US7101912B2 (en) 2002-12-06 2006-09-05 Xenoport, Inc. Carbidopa prodrugs and derivatives, and compositions and uses thereof
US7471862B2 (en) 2002-12-19 2008-12-30 Corning Cable Systems, Llc Dry fiber optic cables and assemblies
US6970629B2 (en) 2002-12-19 2005-11-29 Corning Cable Systems Llc Optical tube assembly having a dry insert and methods of making the same
US20090190890A1 (en) 2002-12-19 2009-07-30 Freeland Riley S Fiber optic cable having a dry insert and methods of making the same
IL154318A (en) 2003-02-06 2010-05-31 Sarah Herzog Memorial Hospital Pharmaceutical compositions for the treatment of movement disorders
ZA200610042B (en) 2004-06-04 2008-06-25 Xenoport Inc Levodopa prodrugs, and compositions and uses thereof
US7323585B2 (en) 2004-06-04 2008-01-29 Xenoport, Inc. Levodopa prodrugs, and compositions and uses thereof
BRPI0619425A2 (pt) * 2005-12-05 2011-10-04 Xenoport Inc mesilato de pró-fármaco de levedopa, composição farmacêutica, método de preparar (2s)-2- amino-3-(3,4-diidróxi fenil) propanoato de mesilato de (2r)-2- fenil carbonilóxi propila e uso do referido composto
US7829592B2 (en) * 2006-12-21 2010-11-09 Xenoport, Inc. Catechol protected levodopa diester prodrugs, compositions, and methods of use
WO2008076458A1 (en) 2006-12-21 2008-06-26 Xenoport, Inc. Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
CA2740017A1 (en) 2008-10-20 2010-04-29 Xenoport, Inc. Methods of synthesizing a levodopa ester prodrug
KR101025612B1 (ko) * 2008-11-10 2011-03-30 한국해양연구원 신규 화합물인 Ramalin 및 그 용도
US8435562B2 (en) 2009-11-09 2013-05-07 Xenoport, Inc. Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
BR112012018256A8 (pt) 2010-03-04 2017-12-19 Orion Corp método de tratamento de doença de parkinson
CN103694127B (zh) * 2013-12-30 2015-04-01 上海交通大学 链霉菌属菌种所产的化合物及该化合物的制备方法和应用
PT3209302T (pt) 2014-10-21 2019-07-19 Abbvie Inc Profármacos de carbidopa e l-dopa e a sua utilização para tratar doença de parkinson
EP3291872A4 (en) 2015-05-06 2019-02-13 SynAgile Corporation PHARMACEUTICAL SUSPENSIONS WITH ACTIVE SUBSTANCES, DEVICES FOR THEIR ADMINISTRATION AND METHOD FOR THEIR USE
WO2019097120A1 (en) 2017-11-16 2019-05-23 Orion Corporation New use and pharmaceutical dosage forms
US20220213128A1 (en) * 2021-01-03 2022-07-07 RockGen Therapeutics LLC L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease
WO2023064783A1 (en) * 2021-10-11 2023-04-20 The Johns Hopkins University Dopa and caffiec acid analogs as novel gcpii inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393923A (en) * 1888-12-04 Samuel preston
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
CH562199A5 (da) * 1970-10-30 1975-05-30 Hoffmann La Roche
BE793426A (fr) * 1971-12-28 1973-06-28 Lannacher Heilmittel G M B H Derives de phenylalanine
US3983138A (en) * 1973-09-25 1976-09-28 Merck & Co., Inc. Amino acid esters
US3939253A (en) * 1973-11-02 1976-02-17 Interx Research Corporation Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa
US4401676A (en) * 1977-06-01 1983-08-30 Merck & Co., Inc. Novel α-amino acids
US4311706A (en) * 1980-01-22 1982-01-19 Interx Research Corporation Novel dopa/dopamine prodrugs

Also Published As

Publication number Publication date
JPH0541626B2 (da) 1993-06-24
AU2234088A (en) 1989-03-23
CA1316180C (en) 1993-04-13
JPH02138A (ja) 1990-01-05
KR890005031A (ko) 1989-05-11
DE3867403D1 (de) 1992-02-13
ATE71083T1 (de) 1992-01-15
PT88526B (pt) 1992-11-30
DK517588D0 (da) 1988-09-16
EP0309827B1 (en) 1992-01-02
IL87765A0 (en) 1989-02-28
CN1032785A (zh) 1989-05-10
US4966915A (en) 1990-10-30
EP0309827A1 (en) 1989-04-05
PT88526A (pt) 1988-10-01

Similar Documents

Publication Publication Date Title
DK517588D0 (da) L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
ATE52498T1 (de) Amidderivate.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
AU1400801A (en) Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
FI881104A (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DE69017855D1 (de) Oxetan-Derivate, ihre Herstellung und ihre Verwendung als Anti-Fungal oder fungizides Mittel.
DK96086D0 (da) 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelsesom laegemidler
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DK609387D0 (da) Heteroarylaminomethandiphosphonsyrer samt deres fremstilling og anvendelse
DK121789D0 (da) 4,5,6,7-tetrahydroisothiazole oe4,5-caapyridinderivater
NO881734D0 (no) Tiadiazolguanidiner og fremgangsmaate for deres fremstilling.
DK0420464T3 (da) 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment